Masimo Corp. (NASDAQ:MASI) shares hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $53.97 and last traded at $53.81, with a volume of 236,112 shares traded. The stock had previously closed at $52.91.

MASI has been the subject of a number of recent analyst reports. Raymond James Financial Inc. downgraded Masimo Corp. from a “strong-buy” rating to an “outperform” rating in a report on Wednesday, June 1st. Zacks Investment Research upgraded Masimo Corp. from a “hold” rating to a “buy” rating and set a $51.00 price target for the company in a report on Friday, May 6th. Roth Capital increased their price target on Masimo Corp. from $40.00 to $50.00 and gave the stock a “buy” rating in a report on Thursday, May 5th. Wedbush increased their price target on Masimo Corp. from $51.00 to $57.00 and gave the stock an “outperform” rating in a report on Thursday, May 5th. Finally, Piper Jaffray Cos. upgraded Masimo Corp. from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $43.00 to $52.00 in a report on Thursday, May 5th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Masimo Corp. has an average rating of “Buy” and a consensus price target of $50.80.

The company has a 50-day moving average of $51.77 and a 200-day moving average of $43.48. The stock has a market cap of $2.57 billion and a PE ratio of 30.89.

Masimo Corp. (NASDAQ:MASI) last issued its quarterly earnings data on Wednesday, May 4th. The company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.43 by $0.10. During the same period last year, the company posted $0.41 earnings per share. The firm had revenue of $171.20 million for the quarter, compared to the consensus estimate of $165.25 million. The business’s revenue was up 10.8% on a year-over-year basis. Equities analysts forecast that Masimo Corp. will post $1.83 earnings per share for the current year.

In related news, insider Jon Coleman sold 4,000 shares of the business’s stock in a transaction dated Wednesday, April 27th. The shares were sold at an average price of $44.00, for a total transaction of $176,000.00. Following the transaction, the insider now owns 4,459 shares in the company, valued at $196,196. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Joe E. Kiani sold 234,952 shares of the business’s stock in a transaction dated Friday, June 3rd. The shares were sold at an average price of $50.09, for a total transaction of $11,768,745.68. Following the transaction, the chief executive officer now owns 313,797 shares in the company, valued at approximately $15,718,091.73. The disclosure for this sale can be found here.

Other institutional investors recently made changes to their positions in the company. Trexquant Investment LP bought a new position in shares of Masimo Corp. during the fourth quarter valued at about $1,009,000. Sawtooth Asset Management Inc. boosted its position in shares of Masimo Corp. by 19,950.0% in the fourth quarter. Sawtooth Asset Management Inc. now owns 27,669 shares of the company’s stock valued at $1,149,000 after buying an additional 27,531 shares in the last quarter. GSA Capital Partners LLP boosted its position in shares of Masimo Corp. by 160.1% in the fourth quarter. GSA Capital Partners LLP now owns 29,151 shares of the company’s stock valued at $1,210,000 after buying an additional 17,944 shares in the last quarter. Globeflex Capital L P boosted its position in shares of Masimo Corp. by 17.5% in the fourth quarter. Globeflex Capital L P now owns 34,900 shares of the company’s stock valued at $1,449,000 after buying an additional 5,200 shares in the last quarter. Finally, Rhumbline Advisers boosted its position in shares of Masimo Corp. by 7.6% in the fourth quarter. Rhumbline Advisers now owns 54,693 shares of the company’s stock valued at $2,270,000 after buying an additional 3,845 shares in the last quarter.

Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.